Zap away arthritis pain? new electromagnetic therapy shows promise
NCT ID NCT06696118
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small pilot study at Mayo Clinic is testing whether Electromagnetic Transduction Therapy (EMTT) can help people with osteoarthritis of the foot or ankle. Twenty participants will receive the treatment, and researchers will measure changes in pain and daily function. The goal is to see if this non-invasive therapy is a viable option for easing arthritis symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2025
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: • Men and women with osteoarthritis of the foot and/or ankle confirmed via radiographs. Exclusion Criteria: • Pacemaker, active cancer, shrapnel, metal in eye, implantable devices that are not compatible with MRIs, concurrent foot or ankle condition or injury, prior foot or ankle surgery for osteoarthritis, steroid, platelet rich plasma, or hyaluronic acid injection within 2 months of the treatment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Osteoarthritis foot are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a single bone screw save ankles from arthritis?
- FDA-Approved ankle replacement under the microscope: will it hold up?
- Which scan is best for foot arthritis? new study aims to find out
- Gentle group workouts may ease joint pain without drugs
- Can a special brace stop ankle arthritis after a break?
- Ankle brace study pulled before it even started